Retour
Prix Evommune Inc (EVMN)
Graphique du cours de l'action EVMN
EVMN Financier
Evommune Inc
$31.57
13.23%
$3.69
À la fermeture : Feb 13, 16:00:00 GMT-5
$32.09
1.64%
$0.52
Post-Marché: Feb 13, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$27.88
Prix d'ouverture
$29.71
Plage de la journée
$29.1 - $32.98
Plage de 52 semaines
$13.88 - $33.2
Volume
1.3M
Volume moyen
534.9K
BPA (TTM)
-5.08
Rendement en dividend
--
Capitalisation boursière
$1.0B
Qu’est-ce que EVMN ?
Evommune, Inc. is a clinical-stage biotechnology company. The company is headquartered in Palo Alto, California and currently employs 45 full-time employees. The company went IPO on 2025-11-06. Its initial clinical development programs are focusing on chronic spontaneous urticaria (CSU), atopic dermatitis (AD) and ulcerative colitis (UC). Its product candidates include EVO756 and EVO301. The firm's advanced clinical-stage product candidate, EVO756, is a potent and highly selective oral small molecule antagonist of MRGPRX2, a receptor predominantly found on mast cells and peripheral sensory neurons, which is initially being evaluated in Phase II trials for the treatment of CSU and AD. The firm's second clinical-stage product candidate, EVO301, is a long-acting fusion protein consisting of an IL-18 binding protein (BP) and an anti-serum albumin Fab-associated (SAFA) domain, which is being evaluated in Phase II trials for the treatment of AD and UC.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.